Cargando…

Parafoveal acute middle maculopathy (PAMM) in sickle cell disease after discontinuation of hydroxyurea

PURPOSE: Paracentral acute middle maculopathy (PAMM) is a rare ophthalmologic emergency involving the intermediate and deep retinal capillary plexus that supply the retina's middle layers. This case report describes an episode of PAMM in a patient with sickle cell disease (SCD) to demonstrate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parikh, Pooja, Mohamed, Mohamed, Bat, Taha, Nero, Alecia, Wang, Angeline, Yates, Sean G., Ufret-Vincenty, Rafael L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685286/ https://www.ncbi.nlm.nih.gov/pubmed/36439654 http://dx.doi.org/10.1016/j.ajoc.2022.101753

Ejemplares similares

Unexpected Etiology in a Case of Bilateral Maculopathy
por: Patel, Prem, et al.
Publicado: (2021)

PAMM and the ischemic cascade associated with radiation retinopathy
por: Wang, Derrick, et al.
Publicado: (2020)

Changes in parafoveal retinal thickness and subfoveal choroidal thickness in a patient with dengue fever-associated maculopathy
por: Yamamoto, Kazuhiro, et al.
Publicado: (2013)

Late PAMM-Like Lesions in a Patient with HIV Retinopathy
por: Kanakis, Menelaos, et al.
Publicado: (2023)

Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)

Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea
por: Yadav, Dhiraj Kumar, et al.
Publicado: (2020)

Foveal avascular zone morphology and parafoveal capillary perfusion in sickle cell retinopathy
por: Lynch, Giselle, et al.
Publicado: (2020)

Comparison of Surgical Outcomes for Uncomplicated Primary Retinal Detachment Repair
por: Heydinger, Stanton, et al.
Publicado: (2023)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

Effective control of sickle cell disease with hydroxyurea therapy
por: Singh, Harminder, et al.
Publicado: (2010)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
por: de Oliveira, Emanuel Almeida Moreira, et al.
Publicado: (2019)

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease
por: Creary, Susan, et al.
Publicado: (2016)

A short report: PAMM, a novel antioxidant protein, induced by oxidative stress
por: Xu, Yan, et al.
Publicado: (2015)

Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective
por: Ciccolini, Joseph, et al.
Publicado: (2016)

Circulating PAMM, a novel antioxidant and anti-inflammatory protein, is elevated in acute SCI
por: Morse, Leslie R., et al.
Publicado: (2020)

West African Crystalline Maculopathy in Sickle Cell Retinopathy
por: Kung, Jennifer S., et al.
Publicado: (2015)

Interocular asymmetry of foveal avascular zone morphology and parafoveal capillary density in sickle cell retinopathy
por: Zhou, Davis B., et al.
Publicado: (2020)

Paracentral Acute Middle Maculopathy
por: Kıyat, Pelin, et al.
Publicado: (2020)

Effect of Hydroxyurea Treatment on the Inflammatory Markers Among Children With Sickle Cell Disease
por: Zahran, Asmaa M., et al.
Publicado: (2020)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
por: da Silva, Luiz Bernardino Lima, et al.
Publicado: (2012)

The reliability of parafoveal cone density measurements
por: Liu, Benjamin S, et al.
Publicado: (2014)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Emerging Science of Hydroxyurea Therapy for Pediatric Sickle Cell Disease
por: Green, Nancy S., et al.
Publicado: (2013)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease
por: Wong, Trisha E., et al.
Publicado: (2021)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
por: Pandey, Akancha, et al.
Publicado: (2022)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Comment on "The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea"
por: Souza, José Carlos, et al.
Publicado: (2012)

Suspected Severe Malaria in a Sudanese Patient Affected by Sickle Cell Disease Who Was Treated with Hydroxyurea
por: Chiopris, Giulia, et al.
Publicado: (2021)

P1489: MANAGEMENT OF SICKLE CELL DISEASE WITH HYDROXYUREA: A SYSTEMATIC REVIEW FROM LOW- AND MIDDLE-INCOME COUNTRIES
por: Paintsil, V., et al.
Publicado: (2022)

Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia
por: Silva, Danilo Grunig Humberto, et al.
Publicado: (2013)

Improving routine outpatient monitoring for patients with sickle-cell disease on hydroxyurea
por: Ward, Joel, et al.
Publicado: (2018)

Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach
por: Nazon, Charlotte, et al.
Publicado: (2019)

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
por: Queiroz, Ana Mach, et al.
Publicado: (2021)

A systematic review on hydroxyurea therapy for sickle cell disease in India
por: Pandey, Apoorva, et al.
Publicado: (2022)

Intensive hydroxyurea dosing in very young children with sickle cell anemia
por: Wang, Winfred C., et al.
Publicado: (2023)

A case of hyperhemolysis syndrome in sickle cell disease and concomitant COVID-19
por: Green, Allen, et al.
Publicado: (2023)

Methanol Intoxication Presenting With Bilateral Optic Neuritis and Paracentral Acute Middle Maculopathy
por: Saad, Sherouk G, et al.
Publicado: (2022)

Conjunctival optical coherence tomography angiography imaging in sickle cell maculopathy()
por: Mgboji, Glory E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tc4gcfi4at6td44abgirbit9j